Vesikari, Itzler et al
| VP7 Serotype | Number of cases† | Efficacy estimate (%) | 95% Confidence interval | |
|---|---|---|---|---|
| PRV N = 34,035 | Placebo N = 34,003 | |||
| G1 | 32 | 414 | 92.3 | 88.2 to 95.0 |
| G2 | 1 | 12 | 91.7 | 34.7 to 99.0 |
| G3 | 3 | 20 | 85.1 | 49.6 to 95.6 |
| G4 | 2 | 20 | 90.1 | 57.2 to 97.7 |
| G9 | 2 | 25 | 92.1 | 66.1 to 98.2 |
N, Number vaccinated.
†Includes all rotavirus AGE cases occurring after the first dose.